About Us

We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.

Technology for Cancer Treatment

Filtricine was founded by Stanford researchers who decoded the way to exploit cancer cell weaknesses by depriving them of nutrients without harming the rest of the body. This scientific breakthrough is known as Targeted Nutrients Deprivation (TND). We can improve lives through providing balanced nutrition to cancer patients while starving cancer cells.  Tality medical food, our first product specifically designed for cancer patients, leverages our ground-breaking research in cell metabolism and nutrition science. Tality is currently being investigated in clinical studies.

Nutrition-Based Interventions for Patient Health

Treating cancer is just the beginning. We want to change the lives of millions of patients around the world without drugs. We are building on the philosophy of nutrition-based interventions for human health: “food as medicine”. Filtricine is working hard to develop products and solutions to improve the quality of life of people living with many common diseases.

Our Team

Dr. John Chant
CEO
Dr. Xiyan Li
CSO & Co-founder
Dr. Jimmy Xin Wang
CTO & Co-founder
Dr. Grace Xiaolu Yang
COO, VP of Research & Co-founder
Mike Partsuf
Senior Food Scientist
Emily Sinovic
Public Relations Consultant
Todd Lorenz
Clinical Development Consultant

Our Advisors

Dr. Mike P Snyder
Chair of Genetics
Stanford University School of Medicine
Peter B Hutt
Former FDA Chief Counsel
Senior Counsel at Covington & Burling LLP
Brad Barnes
Director
Culinary Institute of America
Dr. Dariush Mozaffarian
Dean at the School of Nutrition Science
Tufts University
Dr. Yung-Chi Cheng
Henry Bronson Professor of Pharmacology
Yale University School of Medicine
Dr. Danhua Xiao
Nutrition & Metabolic Physician Specialist
Atlantic Health Metabolic Center
Dr. Joseph V Rodricks
Founding Principal
Ramboll (formerly ENVIRON)
Alister Thomson
Director
Bristol Myers Squibb (Former)
Jeff Depew
Board Director & Committee Chair
Sand Hill Angels
Dr. Wei Jiang
Senior Director
Medical Affairs at MorphoSys

Our Board of Directors

Dr. John Chant
CEO
Dr. Xiyan Li
CSO & Co-founder
Dr. Rami El Assal
Founding Partner at Boutique Venture Partners
Drew Lanza
Founding Partner at Berkeley Catalyst Fund
We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.
© 2022 Filtricine, Inc. All Rights Reserved | by Wuilt